Apotex is transforming osteoporosis care across Canada with Health Canada's green light for DENOZA™, a cutting-edge denosumab biosimilar. This thrilling launch promises to make treatment more accessible and affordable for patients everywhere!
Apotex is transforming osteoporosis care across Canada with Health Canada's green light for DENOZA™, a cutting-edge denosumab biosimilar. This thrilling launch promises to make treatment more accessible and affordable for patients everywhere!
Samsung Bioepis has just reached a thrilling milestone by securing Japan's regulatory approval for its Stelara biosimilar, opening the door to a powerful presence in Asia's rapidly growing biologics market, The Korea Herald reports
